Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study.

Chemotherapy combined with or without targeted therapy remained dominated third-line choice and showed favorable efficacy compared with anti-angiogenic monotherapy. With the application of more types and quantities of effective drugs, patients would achieve better survival.